• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by 3M Company

    7/30/25 1:34:30 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    3M COMPANY

    (Name of Issuer)


    Common Stock, Par Value $.01 Per Share

    (Title of Class of Securities)


    88579Y101

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    88579Y101


    1Names of Reporting Persons

    JPMORGAN CHASE & CO.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    36,252,541.00
    6Shared Voting Power

    142,449.00
    7Sole Dispositive Power

    40,417,332.00
    8Shared Dispositive Power

    122,676.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    40,578,820.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.6 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    3M COMPANY
    (b)Address of issuer's principal executive offices:

    3M Center St. Paul MN 55144-1000
    Item 2. 
    (a)Name of person filing:

    JPMORGAN CHASE & CO.
    (b)Address or principal business office or, if none, residence:

    383 Madison Avenue,, New York, NY 10179
    (c)Citizenship:

    DE
    (d)Title of class of securities:

    Common Stock, Par Value $.01 Per Share
    (e)CUSIP No.:

    88579Y101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    40578820
    (b)Percent of class:

    7.6  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    36252541

     (ii) Shared power to vote or to direct the vote:

    142449

     (iii) Sole power to dispose or to direct the disposition of:

    40417332

     (iv) Shared power to dispose or to direct the disposition of:

    122676

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    J.P. Morgan Trust Company of Delaware; J.P. Morgan Securities LLC; JPMorgan Chase Bank, National Association; JPMorgan Asset Management (UK) Limited; J.P. MORGAN SE; J.P. Morgan (Suisse) SA; JPMorgan Asset Management Holdings Inc.; J.P. Morgan Alternative Asset Management Inc.; J.P. Morgan Investment Management Inc.; JPMorgan Asset Management (China) Company Limited; 55I, LLC
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.


    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    JPMORGAN CHASE & CO.
     
    Signature:Rachel Tsvaygoft
    Name/Title:Vice President
    Date:07/30/2025
    Get the next $MMM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    7/29/2024$110.00 → $150.00Hold → Buy
    Deutsche Bank
    6/13/2024$125.00Peer Perform → Outperform
    Wolfe Research
    6/7/2024$105.00 → $120.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $MMM
    SEC Filings

    View All

    3M Company filed SEC Form 8-K: Leadership Update

    8-K - 3M CO (0000066740) (Filer)

    8/15/25 4:15:41 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by 3M Company

    SCHEDULE 13G - 3M CO (0000066740) (Subject)

    7/30/25 1:34:30 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by 3M Company

    10-Q - 3M CO (0000066740) (Filer)

    7/18/25 11:44:44 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group President Goralski Christian T Jr exercised 6,650 shares at a strike of $130.14 and sold $925,860 worth of shares (6,165 units at $150.18), increasing direct ownership by 20% to 2,900 units (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    8/8/25 9:01:46 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Sr Vice President & CAO Reinseth Theresa E sold $523,741 worth of shares (3,477 units at $150.63), decreasing direct ownership by 58% to 2,561 units (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    8/6/25 9:00:59 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Director Fitterling James R was granted 306 shares (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    7/23/25 4:06:29 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    3M upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded 3M from Equal Weight to Overweight and set a new price target of $170.00 from $140.00 previously

    1/22/25 7:45:34 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M upgraded by UBS with a new price target

    UBS upgraded 3M from Neutral to Buy and set a new price target of $184.00

    11/13/24 8:05:47 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M upgraded by Melius

    Melius upgraded 3M from Hold to Buy

    10/22/24 11:24:35 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., Aug. 15, 2025 /PRNewswire/ -- The 3M Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.73 per share for the third quarter of 2025. The dividend is payable Sept. 12, 2025, to shareholders of record at the close of business on Aug. 25, 2025. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M 3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint,

    8/15/25 2:40:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Kids In Need Foundation and 3M Celebrate 30 Years with Grand Opening of New National Headquarters and Expanded Teacher Resource Center in Little Canada, MN

    New facility addresses out-of-pocket classroom costs by providing free supplies to under-resourced teachers locally and nationwide LITTLE CANADA, Minn., Aug. 7, 2025 /PRNewswire/ -- As many teachers continue to shoulder the burden of rising classroom supply costs—often spending 1-2 paychecks out of pocket each year—Kids In Need Foundation (KINF), a national nonprofit focused on supporting under-resourced teachers and students, is proud to announce the grand opening of its new national headquarters and expanded Teacher Resource Center in Little Canada, Minnesota. This milestone event, running August 11–15, 2025, also celebrates KINF's 30 years of impact and a long-standing 20+ year partnershi

    8/7/25 1:23:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Scotch Brand celebrates 100 Years of adhesive solutions and industrial innovation

    A century of innovation from automotive and packaging to construction and electronics  ST. PAUL, Minn., July 28, 2025 /PRNewswire/ -- This year marks the 100th anniversary of Scotch™ Brand, celebrating a legacy of breakthrough innovation that began in 1925 with the creation of Scotch Masking Tape to help auto-body painters detail cars without damaging existing paint jobs. Today, Scotch Brand is a trusted global partner across nearly every industry, offering an extensive portfolio of more than 600 adhesives, sealants, and fillers.  To commemorate the centennial, 3M is sharing c

    7/28/25 4:40:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    View All

    3M Annual Meeting Results

    ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company. Preliminary Shareholder Voting Results 3M shareholders today voted on the following business items: 1) Shareholders supported 11 directors for one-year terms to expire at the company's 2026 Annual Meeting: David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford

    5/13/25 4:30:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces New Board Appointments

    William Brown to become Chairman of the Board of DirectorsMike Roman to retire as Executive Chairman and Director and become Executive Advisor to the BoardDavid Bozeman elected to the BoardAmy Hood does not intend to stand for reelectionST. PAUL, Minn., Feb. 10, 2025 /PRNewswire/ -- 3M (NYSE:MMM) announced today changes to its Board of Directors and Board leadership structure. William M. "Bill" Brown, 3M's Chief Executive Officer and Director, has been appointed by the Board to serve as its Chairman, effective March 1, 2025 in addition to his current responsibilities.  Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman,

    2/10/25 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M joins consortium to accelerate semiconductor technology in the US

    ST. PAUL, Minn., Feb. 3, 2025  /PRNewswire/ -- 3M is expanding its commitment to the semiconductor industry by joining the US-JOINT Consortium, a strategic partnership of 12 leading semiconductor suppliers. The consortium drives research and development in next-generation semiconductor advanced packaging and back-end processing technologies anchored by a new cutting-edge facility in Silicon Valley. "As the demands of AI and other high performance computing technologies increase, suppliers must work together to provide comprehensive solutions to tough challenges on increasingly

    2/3/25 10:55:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Financials

    Live finance-specific insights

    View All

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., Aug. 15, 2025 /PRNewswire/ -- The 3M Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.73 per share for the third quarter of 2025. The dividend is payable Sept. 12, 2025, to shareholders of record at the close of business on Aug. 25, 2025. 3M has paid dividends to its shareholders without interruption for more than 100 years. About 3M 3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint,

    8/15/25 2:40:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Reports Second-Quarter 2025 Results, Increases Full-Year EPS Guidance

    GAAP sales of $6.3 billion, up 1.4%; operating margin 18.0%, down (230) bps; EPS of $1.34, down 38%, all YoYAdjusted sales of $6.2 billion with organic growth of 1.5% YoYAdjusted operating margin of 24.5%, up 290 bps YoYAdjusted EPS of $2.16, up 12% YoYOperating cash flow of $(1.0) billion with adjusted free cash flow of $1.3 billion2025 adjusted EPS guidance increased from $7.60 - $7.90 to $7.75 - $8.00, including the impact of tariffsST. PAUL, Minn., July 18, 2025 /PRNewswire/ -- 3M (NYSE: MMM) today reported second-quarter 2025 results. "We delivered strong results in the second quarter, posting positive organic sales growth and double-digit EPS growth," said William Brown, 3M Chairman an

    7/18/25 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces Upcoming Investor Event

    ST. PAUL, Minn., July 3, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event: Second-quarter 2025 earnings conference call on Friday, July 18, 2025, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M

    7/3/25 10:10:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/23 10:54:46 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/22 3:15:56 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care